Safety and Efficacy of Sildenafil Citrate for the Treatment of Female Sexual Arousal Disorder: A Double-Blind, Placebo Controlled Study

Seek immediate medical help if symptoms of an allergic reaction or anaphylaxis occur.

• The use of sildenafil in women is still under scientific investigation.
• Some women report benefits, but evidence is not definitive.
• Potential risks must be carefully weighed against benefits.
• Proper medical guidance is essential for safe use.

A person should speak with a doctor before taking any supplements to boost libido. The doctor can advise on the suitabilty of the products, and they may recommend medications such as Addyi and Vyleesi.

• Sildenafil's effect duration in women may range from 4 to 6 hours.
• It may help women experiencing low libido linked to blood flow issues.
• The drug’s efficacy in women is less predictable than in men.
• Female sexual dysfunction has multiple causes beyond blood flow.

Vyleesi (bremelanotide) and Addyi (flibanserin) can help treat female sexual interest/arousal disorder (FSIAD) in premenopausal people. The FDA has not approved Viagra for use in females. The FDA also advises against taking over-the-counter supplements that are marketed to boost libido. Medication may not treat all causes of low sexual desire.

MeSH terms

The safety profile of sildenafil in women appears to be similar to that observed in men, with common side effects being relatively mild. The study concluded that any genital physiological effect of sildenafil was not perceived as improving the sexual response in the broad spectrum of women with FSAD who participated in the trial1. However, it also suggested that future research could explore whether more specific subgroups of women with FSAD might benefit from sildenafil treatment. This indicates a need for further studies to identify potential responders and optimize treatment protocols. The quest for a 'Female Viagra' continues, with sildenafil citrate showing limited efficacy in improving sexual response in women with FSAD.

A note about sex and gender

While the safety profile is acceptable, the lack of significant benefits underscores the need for more targeted research. Future studies should focus on identifying specific subgroups of women who may respond to sildenafil and exploring alternative treatment options to address the complex nature of female sexual dysfunction. The content presented in this blog is generated by Consensus, an AI-powered academic search engine, and is based on publicly available scientific literature. While every effort is made to provide accurate, up-to-date, and well-researched information, the content is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. A person can contact a doctor for advice on suitable medications and other ways to help improve their libido. We assessed the tolerability, safety and efficacy of sildenafil for the treatment of women with sexual dysfunction secondary to multiple sclerosis, as well as the role of somatosensory evoked potential neurophysiological testing. We performed a double-blind, randomized, placebo controlled, crossover study investigating the effects of sildenafil in women with multiple sclerosis and sexual dysfunction. Pudendal and tibial evoked potentials were also recorded. A total of 19 women completed the 2 arms of the double-blind phase and 12 completed the optional open label extension phase.

There was a significant correlation between the latency of tibial and pudendal evoked potentials. Sildenafil only appeared to produce limited benefit in certain individuals with female sexual dysfunction. Some measure of the extent of neurological deficit in these patients could be ascertained from the latency of tibial evoked potentials, which correlated with pudendal evoked potentials. However, it could not predict the extent of sexual dysfunction. Sildenafil is unlikely to help all patients with neurogenic female sexual dysfunction.

Patients and Methods

This article describes the FDA-approved medications for low libido in females, including how they work and the possible side effects. This article will use the terms “male,” “female,” or both to refer to sex assigned at birth. The FDA has approved two drugs to address FSIAD: Vyleesi (bremelanotide) and Addyi (flibanserin). Addyi was the first drug approved to treat FSIAD. Addyi is designed for premenopausal people, and is available as a pill.

Osphenia (Ospemifene)

A person takes this drug daily before bed, even if they do not intend to have sex that day. It can take no more than 8 weeks to see an increase in sexual desire, though some people experience the effects much sooner. The FDA states that Vyleesi medication can treat FSIAD in premenopausal females. A person injects it into their thigh or stomach at least 45 minutes before having sex. The effects can last for up to 24 hours. 1 : Sexual dysfunction in the United States: prevalence and predictors. 2 : Female sexual dysfunction in multiple sclerosis: a review. 3 : Sexual dysfunction in multiple sclerosis: a case-control study.I.

Frequently asked questions

However, some people do not metabolize CYP2C19, an enzyme protein, effectively, and this can cause levels of the drug to build up, resulting in side effects. Vyleesi lasts around 2.7 hours, and the average time it takes to clear the body is 6.5 hours. The drug may slow how fast the body can process other medication. Vyleesi and Addyi treat FSIAD in premenopausal people. No research has tested buy sildenafil citrate online canada the drug in people during or after menopause. 4 : Sexual function in women with advanced multiple sclerosis. 5 : Measurement of vaginal and minor labial oxygen tension for the evaluation of female sexual function. 6 : Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves.

Treatment Information

People should not use the drug more than eight times per month. The table below compares Vyleesi and Addyi: Viagra is not FDA approved for use in females. To understand why, it can help to understand what Viagra was designed to do in the male body. Usually, after sexual stimulation in a male, there is a release of nitric oxide, which increases levels of a regulatory agent in cells called cyclic guanosine monophosphate (cGMP). This increase in cGMP causes smooth muscle relaxation, and it leads to increased blood flow to the penis, resulting in an erection.

Female sexual response: the role of drugs in the management of sexual dysfunction

In males, an erection goes down when an enzyme called phosphodiesterase type 5 (PDE-5) breaks down. Anyone who would like to try Viagra should ask a medical professional, who may prescribe the drug off-label. Vyleesi targets melanocortin receptors, which are linked to sexual function. The drug modulates the brain pathways involved in sexual response. After 3 days of taking the medication, there is a steady level of the drug in the body. 9 : Viagra (sildenafil citrate) for the treatment of erectile dysfunction in men with multiple sclerosis. 10 : Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. 11 : Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury.

How does Viagra work?

Always consult a qualified healthcare professional before making any decisions regarding medical conditions, treatments, or medications. The AI system's analysis may not cover all perspectives, emerging research, or individual cases, and it is not a substitute for professional expertise. Neither the blog publisher nor the developers of the AI-powered search engine are responsible for any actions taken based on the information provided in this content. Use of this information is at your own risk. Citations to the original scientific studies are included for reference, but these studies should be reviewed in full and interpreted with the guidance of a healthcare or research professional.

Polymer-based nitric oxide therapies: Recent insights for biomedical applications

If you are experiencing a medical emergency, please seek immediate attention from a healthcare provider. Consensus searches through 220M+ peer reviewed research papers and provides you the best insights from them. In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “Viagra for females.” The Food and Drug Administration (FDA) have approved two drugs — flibanserin (Addyi) and bremelanotide (Vyleesi) — to address low desire or arousal in females. However, both are approved for use only in people who have not yet entered menopause. 12 : Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. 13 : Sexual problems in patients suffering from multiple sclerosis. 14 : Efficacy and tolerability of Viagra® (sildenafil citrate) in women with sexual arousal disorder: a double-blind, placebo-controlled study. 15 : Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. 16 : Sildenafil for sexual dysfunction in women taking antidepressants. 17 : Validated instruments for assessing female sexual function. 18 : Cortical evoked potentials of the dorsal nerve of the clitoris and female sexual dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition. 20 : Female sexual response: the role of drugs in the management of sexual dysfunction. From the Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom I use to love having sex a lot now can't even "express, happiness" anyone know how to fix this. All quotes opinions and thoughts are welcome and much ablidged!

The information on this page reflects personal experiences shared by our community members.

What should I do in case of overdose?

The medications may be beneficial for premenopausal people who: Factors that are lined with a reduced sex drive in females include: certain health conditions, such as diabetes and heart disease The FDA-approved drugs for FSIAD can have the following side effects. The side effects of Addyi can include: those who have consumed alcohol in the last 2 hours The drug can cause severe low blood pressure and fainting in people who take it with alcohol or who have liver conditions. irritation or a rash at the injection site darkening of the skin, resulting in dark spots called hyperpigmentation on the gums, face and breasts Vyleesi may reduce the efficiency of oral medications due to slower emptying of the gastric system. It can also make drugs containing naltrexone to treat alcohol and opioid addiction less effective, so anyone taking a drug that contains naltrexone should avoid Vyleesi. Like other drugs, Vyleesi and Addyi can cause allergic reactions.